基本資料
種類: ETF
費用比率%: 0.60
資產淨值: 31.72
成立日期: 11/12/2017
 
分析
市值分佈:
74.04%
大市值
3.95%
中市值
1.36%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 14/11/2026 05:06) 總持有投資項目: 314  
0%
 
100%
     10大 (23.97%)
代號 名稱 佔比% ▼ 持有日期
OVIDOvid Therapeutics0.0130/10/2026
MDXGMiMedx Group0.0130/10/2026
VNDAVanda Pharmaceuticals0.0130/10/2026
GENGen Digital0.0130/10/2026
TRMBTrimble0.0130/10/2026
ASMBAssembly Biosciences0.0130/10/2026
AURAAura Biosciences0.0130/10/2026
SWKSSkyworks Solutions0.0130/10/2026
FRC--0.0131/03/2023
LXEOLexeo Therapeutics0.0130/10/2026
CBIOCrescent Biopharma Inc0.0130/10/2026
FTHFaeth Therapeutics Inc0.0130/10/2026
CMPXCompass Therapeutics0.0130/10/2026
BBOTBridgeBio Oncology Therapeutics Inc0.00330/10/2026
  1    2    3    4    5    6    7    8    9    10    11    12    13    14    15   16  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.